BRIEF-Aridis Pharmaceuticals Says License Agreement With The Serum Institute Of India

  • Reuters
  • Stock Market News
BRIEF-Aridis Pharmaceuticals Says License Agreement With The Serum Institute Of India
Credit: © Reuters.

Sept 30 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :

* ARIDIS PHARMACEUTICALS EXECUTES LICENSE AGREEMENT WITH THE SERUM INSTITUTE OF INDIA, LTD. FOR EXCLUSIVE RIGHTS TO PRODUCTS AND UTILIZATION OF MABIGX® PLATFORM TECHNOLOGY

* ARIDIS PHARMACEUTICALS - UNDER DEAL, CO TO RECEIVE REMAINING UPFRONT CASH PAYMENT OF $10 MILLION, IN ADDITION TO $5 MILLION THAT WAS INITIALLY RECEIVED

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles